COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,680 Articles (22,913 medRxiv, 8,767 bioRxiv)

Most recent first Previous |  Page 1644: Articles 16431-16440  | Next

The relationship between human mobility measures and SAR-Cov-2 transmission varies by epidemic phase and urbanicity: results from the United States
Kishore, N., Taylor, A. R., Jacob, P. E., Vembar, N., Cohen, T., Menzies, N. A., Buckee, C.
10.1101/2021.04.15.21255562 — Posted: 2021-04-20
Emergence of the SARS-CoV-2 B.1.1.7 lineage and its characteristics at an outpatient testing site in Berlin, Germany, January-March 2021
van Loon, W., Rössig, H., Burock, S., Hofmann, J., Bernhard, J., Linzbach, E., Pettenkofer, D., Schönfeld, C., Gertler, M., Seybold, J., Kurth, T., Mockenhaupt, F. P.
10.1101/2021.04.15.21255389 — Posted: 2021-04-20
Survival analysis methods for analysis of hospitalization data: Application to COVID-19 patient hospitalization experience
Rathouz, P. J., Valencia, V., Chang, P., Morton, D., Yang, H., Surer, O., Fox, S. J., Meyers, L. A., Matsui, E. C., Haynes, A. B.
10.1101/2021.04.14.21255511 — Posted: 2021-04-20
On whether therapeutic plasma exchange is an effective cure for severe/critical COVID-19 pneumonia
Cegolon, L., Einollahi, B., Imanizadeh, S., Rezapour, M., Javanbakht, M., Nikpouraghdam, M., Abolghasemi, H., Mastrangelo, G.
10.1101/2021.04.19.21255657 — Posted: 2021-04-20
Diagnostic accuracy of SARS-CoV-2 rapid antigen detection testing in symptomatic and asymptomatic children in the clinical setting
L'Huillier, A., Lacour, M., Sadiku, D., Gadiri, M. A., De Siebenthal, L., Schibler, M., Eckerle, I., Pinosch, S., Kaiser, L., Gervaix, A., Glangetas, A., Galetto-Lacour, A., Lacroix, L.
10.1101/2021.04.15.21255577 — Posted: 2021-04-20
COVID-19 transmission in a theme-park
Aruffo, E., Athar, S., Raad, A., Ali, M. A., Althubyani, M., Chow, C., Ruma, M., Liu, C., Wu, J., Asgary, A., Kong, J. D., Heffernan, J. M.
10.1101/2021.04.15.21255560 — Posted: 2021-04-20
Pharmacokinetics and safety of XAV-19, a swine glyco-humanized polyclonal anti-SARS-CoV-2 antibody, for COVID-19-related moderate pneumonia: a randomized, double-blind, placebo-controlled, phase IIa study
Gaborit, B., Dailly, E., Vanhove, B., Josien, R., Lacombe, K., Dubee, V., Ferre, V., Brouard, S., Ader, F., Vibet, M.-A., Le Thuaut, A., Danger, R., Omnes, A. O., Berly, L., Chiffoleau, A., Jobert, A., Duvaux, O., Raffi, F.
10.1101/2021.04.15.21255549 — Posted: 2021-04-20
Asymptomatic or mild symptomatic SARS-CoV-2 infection elicits durable neutralizing antibody responses in children and adolescents
Garrido, C., Hurst, J. H., Lorang, C. G., Aquino, J. N., Rodriguez, J., Pfeiffer, T. S., Singh, T., Semmes, E. C., Lugo, D. J., Rotta, A. T., Turner, N. A., Burke, T. W., McClain, M. T., Petzold, E. A., Permar, S. R., Moody, M. A., Woods, C. W., Kelly, M. S., Fouda, G. G.
10.1101/2021.04.17.21255663 — Posted: 2021-04-20
Evaluation of seven different rapid methods for nucleic acid detection of SARS-COV-2 virus
Mahmoud, S., Ibrahim, E., Ganesan, S., Thakre, B., Teddy, J., Raheja, P., Zaher, W.
10.1101/2021.04.15.21255533 — Posted: 2021-04-20
Self-collected oral, nasal and saliva samples yield sensitivity comparable to professional-collected oro-nasopharyngeal swabs in SARS-CoV-2 diagnosis
Gertler, M., Krause, E., van Loon, W., Krug, N., Kausch, F., Rohardt, C., Roessig, H., Michel, J., Nitsche, A., Mall, M. A., Nikolai, O., Hommes, F., Burock, S., Lindner, A. K., Mockenhaupt, F. P., Pison, U., Seybold, J.
10.1101/2021.04.13.21255345 — Posted: 2021-04-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).